The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy

被引：0
|
作者：
Byung-Hoon Min
Jeong Mo Bae
Eui Jin Lee
Hong Suk Yu
Young-Ho Kim
Dong Kyung Chang
Hee Cheol Kim
Cheol Keun Park
Suk-Hee Lee
Kyoung-Mee Kim
Gyeong Hoon Kang
机构：
[1] Sungkyunkwan University School of Medicine,Departments of Medicine, Samsung Medical Center
[2] Seoul National University College of Medicine,Department of Pathology
[3] Sungkyunkwan University School of Medicine,Department of Pathology, Samsung Medical Center
[4] Sungkyunkwan University School of Medicine,Department of Surgery, Samsung Medical Center
[5] Daehang Hospital,Department of Pathology
来源：
BMC Cancer | / 11卷
关键词：
KRAS Mutation; BRAF Mutation; MGMT Methylation; Sessile Serrate Adenoma; Mucinous Histology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit
    Song, Kai
    Guo, You
    Wang, Xianlong
    Cai, Hao
    Zheng, Weicheng
    Li, Na
    Song, Xuekun
    Ao, Lu
    Guo, Zheng
    Zhao, Wenyuan
    FASEB JOURNAL, 2019, 33 (01): : 151 - 162
  • [22] A retrospective analysis using deep-learning models for prediction of survival outcome and benefit of adjuvant chemotherapy in stage II/III colorectal cancer
    Li, Xingyu
    Jonnagaddala, Jitendra
    Yang, Shuhua
    Zhang, Hong
    Xu, Xu Steven
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (08) : 1955 - 1963
  • [23] A retrospective analysis using deep-learning models for prediction of survival outcome and benefit of adjuvant chemotherapy in stage II/III colorectal cancer
    Xingyu Li
    Jitendra Jonnagaddala
    Shuhua Yang
    Hong Zhang
    Xu Steven Xu
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 1955 - 1963
  • [24] MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin
    E Cecchin
    G Perrone
    S Nobili
    J Polesel
    E De Mattia
    C Zanusso
    P Petreni
    S Lonardi
    N Pella
    M D'Andrea
    D Errante
    F Rizzolio
    T Mazzei
    I Landini
    E Mini
    G Toffoli
    The Pharmacogenomics Journal, 2015, 15 : 219 - 225
  • [25] Different Prognostic Impacts of Fusobacterium Nucleatum Based on Tumor Location in Stage II/III Colorectal Carcinomas Treated with Adjuvant FOLFOX Chemotherapy
    Kim, Jung Ho
    Cho, Nam-Yun
    Bae, Jeong Mo
    Kang, Gyeong Hoon
    MODERN PATHOLOGY, 2018, 31 : 276 - 276
  • [26] Different Prognostic Impacts of Fusobacterium Nucleatum Based on Tumor Location in Stage II/III Colorectal Carcinomas Treated with Adjuvant FOLFOX Chemotherapy
    Kim, Jung Ho
    Cho, Nam-Yun
    Bae, Jeong Mo
    Kang, Gyeong Hoon
    LABORATORY INVESTIGATION, 2018, 98 : 276 - 276
  • [27] MTHFR-1298 A > C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin
    Cecchin, E.
    Perrone, G.
    Nobili, S.
    Polesel, J.
    De Mattia, E.
    Zanusso, C.
    Petreni, P.
    Lonardi, S.
    Pella, N.
    D'Andrea, M.
    Errante, D.
    Rizzolio, F.
    Mazzei, T.
    Landini, I.
    Mini, E.
    Toffoli, G.
    PHARMACOGENOMICS JOURNAL, 2015, 15 (03): : 219 - 225
  • [28] Effect of age on survival benefit of adjuvant chemotherapy in elderly stage III colon cancer patients: a population-based analysis
    Zuckerman, I. H.
    Davidoff, A. J.
    Onukwugha, E.
    Pandya, N.
    Gardner, J. F.
    Seal, B.
    Obeidat, N.
    Rapp, T.
    Mullins, C. D.
    Choti, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [29] Relationship of Polymorphism of the Tandem Repeat Sequence in the Thymidylate Synthase Gene and the Survival of Stage III Colorectal Cancer Patients Receiving Adjuvant 5-Flurouracil-Based Chemotherapy
    Park, Chi-Min
    Lee, Woo Yong
    Chun, Ho-Kyung
    Cho, Yong Beom
    Yun, Hae Ran
    Heo, Jin Seok
    Yun, Seong Hyeon
    Kim, Hee Cheol
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 101 (01) : 22 - 27
  • [30] CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer
    Xiaofei Zhang
    Hideki Shimodaira
    Hiroshi Soeda
    Keigo Komine
    Hidekazu Takahashi
    Kota Ouchi
    Masahiro Inoue
    Masanobu Takahashi
    Shin Takahashi
    Chikashi Ishioka
    International Journal of Clinical Oncology, 2016, 21 : 1091 - 1101
12345